Brett Hartmann, MD
Family Medicine · Lafayette Hill, PANPI 1962639575
Payments from drug & device makers
Across 331 payments — averaging $16.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$905
- AstraZeneca$581
- Novo Nordisk$542
- Pfizer$407
- Lilly USA, LLC$385
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$210
- plus $2K from 31 others
What the payments were for
- Food & beverage$5,298100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 68 | $905 |
| AstraZeneca | 31 | $581 |
| Novo Nordisk | 35 | $542 |
| Pfizer | 26 | $407 |
| Lilly USA, LLC | 24 | $385 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 20 | $210 |
| Gilead | 14 | $202 |
| Merck | 13 | $197 |
| Amgen(2 entities) | 10 | $168 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $143 |
| Exact Sciences | 6 | $139 |
| Access Pro Medical, LLC | 1 | $131 |
| Astellas Pharma US Inc | 6 | $121 |
| Idorsia Pharmaceuticals US Inc | 6 | $119 |
| Bayer | 5 | $100 |
| GSK | 5 | $98 |
| Boehringer Ingelheim | 4 | $74 |
| Abbott | 3 | $72 |
| Sanofi-aventis U.S. LLC | 4 | $72 |
| Kowa Pharmaceuticals America, Inc. | 5 | $68 |
| Bausch Health US, LLC | 3 | $66 |
| Johnson & Johnson | 4 | $57 |
| Teva Pharmaceuticals USA, Inc. | 4 | $56 |
| Novartis | 3 | $42 |
| Regeneron Healthcare Solutions, Inc. | 2 | $37 |
| Axsome Therapeutics, Inc. | 2 | $35 |
| Lundbeck LLC | 2 | $35 |
| Shield Therapeutics Inc | 2 | $33 |
| Eisai Inc. | 2 | $32 |
| Biohaven Pharmaceuticals, Inc. | 2 | $32 |
| Sumitomo Pharma America, Inc. | 2 | $29 |
| Amarin Pharma, Inc. | 1 | $22 |
| VBI Vaccine (delaware) Inc. | 1 | $21 |
| Paratek Pharmaceuticals, Inc. | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
| Dexcom, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Matriderm$131
How this compares
$5,298 in reported general payments places this provider in the 85th percentile of 4,967 family medicine providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 166 | $172,601 |
| OzempicSemaglutide | 97 | $105,630 |
| TrulicityDulaglutide | 48 | $59,347 |
| EliquisApixaban | 72 | $58,735 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 72 | $46,848 |
| JardianceEmpagliflozin | 45 | $44,504 |
| RybelsusSemaglutide | 32 | $35,483 |
| FarxigaDapagliflozin Propanediol | 40 | $34,451 |
| JanuviaSitagliptin Phosphate | 46 | $28,878 |
| Xigduo XrDapaglifloz Propaned/Metformin | 30 | $28,781 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 25 | $18,381 |
| MyrbetriqMirabegron | 26 | $15,696 |
| XareltoRivaroxaban | 17 | $14,119 |
| LinzessLinaclotide | 26 | $13,685 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 22 | $13,639 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $385 | $231,949214 claims |
| Novo NordiskOzempic, Rybelsus | $542 | $141,113129 claims |
| Boehringer IngelheimSynjardy Xr, Jardiance | $74 | $91,352117 claims |
| PfizerEliquis | $407 | $58,73572 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $581 | $48,09062 claims |
| MerckJanuvia, Belsomra | $197 | $37,58366 claims |
| Johnson & JohnsonXarelto, Procrit | $57 | $26,58428 claims |
| GSKTrelegy Ellipta | $98 | $18,38125 claims |
| AbbVieLinzess, Synthroid | $905 | $15,99665 claims |
| Astellas Pharma US IncMyrbetriq | $121 | $15,69626 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,967 family medicine providers in Pennsylvania.
Other family medicine in Lafayette Hill
- Kem YenalPhila$12.6M
- Marcy FleckerSmithfield$6.9M
- Tiffany PlutoScottdale$4.8M
- Bryce PalchickPittsburgh$4.7M
- Harris CohenHorsham$3.7M
- Shari RozenPittsburgh$2.9M
- Richard CookUniontown$2.1M
- Bruce GebhardtErie$2.1M
- Peter CognettiScranton$1.9M
- Bradley FoxErie$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.